Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) EBT Margin: 2022-2025

Historic EBT Margin for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to -16,259.45%.

  • Prokidney's EBT Margin fell 218600945.00% to -16,259.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -20,906.18%, marking a year-over-year decrease of 138175618.00%. This contributed to the annual value of -215,701.32% for FY2024, which is 129445965.00% down from last year.
  • Prokidney's EBT Margin amounted to -16,259.45% in Q3 2025, which was up 0.51% from -16,342.53% recorded in Q2 2025.
  • Prokidney's EBT Margin's 5-year high stood at 2,169,750.00% during Q3 2024, with a 5-year trough of -61,553.95% in Q4 2024.
  • Its 3-year average for EBT Margin is 892,971.23%, with a median of 846,450.00% in 2023.
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 193,658,966bps in 2023, then plummeted by 218,600,945bps in 2025.
  • Over the past 4 years, Prokidney's EBT Margin (Quarterly) stood at 1,291,750.00% in 2022, then crashed by 66,065,000bps to 631,100.00% in 2023, then plummeted by 69,265,395bps to -61,553.95% in 2024, then slumped by 218,600,945bps to -16,259.45% in 2025.
  • Its EBT Margin was -16,259.45% in Q3 2025, compared to -16,342.53% in Q2 2025 and -16,243.91% in Q1 2025.